Research Article

Targeting the EZH2-PPAR Axis Is a Potential Therapeutic Pathway for Pancreatic Cancer

Figure 1

The protein expression levels of EZH2, H3K27ac, and H3K27me3 in cells of PANC-1 and AsPC-1. (a) Representative bands of western blot of EZH2, H3K27ac, H3K27me3, and histone H3 in cells of H6C7, PANC-1, and AsPC-1. (b) The relative band intensity of EZH2 in cells of H6C7, PANC-1, and AsPC-1. (c) The relative band intensity of H3K27ac in cells of H6C7, PANC-1, and AsPC-1. (d) The relative band intensity of H3K27me3 in cells of H6C7, PANC-1, and AsPC-1. (e) The relative mRNA level of EZH2 in cells of H6C7, PANC-1, and AsPC-1. The values were expressed as the ( for each group). vs. the H6C7 group.
(a)
(b)
(c)
(d)
(e)